CA125-Guided Diuretic Treatment Versus Usual Care in Patients With Acute Heart Failure and Renal Dysfunction.


Por: Núñez J, Llàcer P, Garcia-Blas, S, Bonanad, C, Ventura, S, Núñez JM, Sanchez, R, Facila, L, de la Espriella, R, Vaquer, J, Cordero, A, Roque, M, Chamorro, C, Bodi, V, Valero, E, Santas, E, Del Carmen Moreno, M, Miñana G, Carratala, A, Rodriguez, E, Mollar, A, Palau, P, Bosch, M, Bertomeu-Gonzalez, V, Lupon, J, Navarro, J, Chorro, F, Gorriz, J, Sanchis, J, Voors, A, Bayes-Genis, A and IMPROVE-HF Investigators

Publicada: 1 mar 2020 Ahead of Print: 15 ago 2019
Categoría: Medicine (miscellaneous)

Resumen:
BACKGROUND: The optimal diuretic treatment strategy for patients with acute heart failure and renal dysfunction remains unclear. Plasma carbohydrate antigen 125 (CA125) is a surrogate of fluid overload and a potentially valuable tool for guiding decongestion therapy. The aim of this study was to determine if a CA125-guided diuretic strategy is superior to usual care in terms of short-term renal function in patients with acute heart failure and renal dysfunction at presentation. METHODS: This multicenter, open-label study randomized 160 patients with acute heart failure and renal dysfunction into 2 groups (1:1). Loop diuretics doses were established according to CA125 levels in the CA125-guided group (n?=?79) and in clinical evaluation in the usual-care group (n?=?81). Changes in estimated glomerular filtration rate (eGFR) at 72 and 24 hours were the co-primary endpoints, respectively. RESULTS: The mean age was 78 ± 8 years, the median amino-terminal pro-brain natriuretic peptide was 7765 pg/mL, and the mean eGFR was 33.7 ± 11.3 mL/min/1.73m(2). Over 72 hours, the CA125-guided group received higher furosemide equivalent dose compared to usual care (P?=?0.011), which translated into higher urine volume (P?=?0.042). Moreover, patients in the active arm with CA125 >35 U/mL received the highest furosemide equivalent dose (P <0.001) and had higher diuresis (P?=?0.013). At 72 hours, eGFR (mL/min/1.73m(2)) significantly improved in the CA125-guided group (37.5 vs 34.8, P?=?0.036), with no significant changes at 24 hours (35.8 vs 39.5, P?=?0.391). CONCLUSION: A CA125-guided diuretic strategy significantly improved eGFR and other renal function parameters at 72 hours in patients with acute heart failure and renal dysfunction.

Filiaciones:
Núñez J:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Llàcer P:
 Internal Medicine Department, Hospital de Manises, Manises, Valencia, Spain

Garcia-Blas, S:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Bonanad, C:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

:
 Internal Medicine Department, Hospital de La Plana, Villa-Real, Castellón, Spain

:
 Critical Care Unit, Hospital Universitario del Vinalopó, Elche, Alicante, Spain

:
 Internal Medicine Department, Hospital Virgen de Los Lirios, Alcoy, Spain

Facila, L:
 Cardiology Department, Hospital General Universitario de Valencia, Valencia, Spain

de la Espriella, R:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

Vaquer, J:
 Biochemistry Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, INCLIVA, Valencia, Spain

:
 Cardiology Department, Hospital Universitario San Juan de Alicante, San Juan de Alicante, Alicante, Spain

Roque, M:
 Cardiology Department, Hospital Clínic de Barcelona, Barcelona, Spain

:
 Internal Medicine Department, Hospital Virgen de Los Lirios, Alcoy, Spain

Bodi, V:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Valero, E:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Santas, E:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

Del Carmen Moreno, M:
 Internal Medicine Department, Hospital de Manises, Manises, Valencia, Spain

Miñana G:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Carratala, A:
 Biochemistry Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, INCLIVA, Valencia, Spain

Rodriguez, E:
 Biochemistry Department, Hospital Clínico Universitario de Valencia, Universidad de Valencia, INCLIVA, Valencia, Spain

Mollar, A:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

:
 Cardiology Department, Hospital General Universitario de Castellón. Universitat Jaume I, Castellón, Spain

:
 Internal Medicine Department, Hospital de La Plana, Villa-Real, Castellón, Spain

:
 Cardiology Department, Hospital Universitario San Juan de Alicante, San Juan de Alicante, Alicante, Spain

Lupon, J:
 CIBER Cardiovascular

 Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain

Navarro, J:
 Hospital Clínico Universitario, INCLIVA. Universitat de València, Valencia, Spain

Chorro, F:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Gorriz, J:
 Nephrology Department, Hospital Clínico Universitario, INCLIVA. Universitat de València, Valencia, Spain

Sanchis, J:
 Cardiology Department, Hospital Clínico Universitario de Valencia, Universitat de València, INCLIVA, Valencia, Spain

 CIBER Cardiovascular

Voors, A:
 Cardiology Department, University Medical Center Groningen, Netherlands

Bayes-Genis, A:
 CIBER Cardiovascular

 Cardiology Department and Heart Failure Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Department of Medicine, Autonomous University of Barcelona, Barcelona, Spain.
ISSN: 00029343





AMERICAN JOURNAL OF MEDICINE
Editorial
ELSEVIER SCIENCE INC, 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 133 Número: 3
Páginas: 370
WOS Id: 000517813300039
ID de PubMed: 31422111
imagen Green Published

MÉTRICAS